Loading organizations...
§ Private Profile · Shanghai, Shanghai, China
Innovative biopharmaceuticals for cancer and autoimmune disease treatment.
QureBio has raised $45.4M across 2 funding rounds.
QureBio has raised $45.4M in total across 2 funding rounds.
QureBio has raised $45.4M in total across 2 funding rounds.
QureBio's investors include Fan Rongkui, Lihehongxin Venture Capital Partnership, Longmen Capital, Oriza Holdings.
QureBio has raised $45.4M across 2 funding rounds. Most recently, it raised $14.0M Series C in June 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 5, 2025 | $14M Series C | FAN Rongkui | — | Announced |
| Dec 24, 2021 | $31.4M Series B | — | Lihehongxin Venture Capital Partnership, Longmen Capital, Oriza Holdings | Announced |